MPO and cancer: This was not seen for CD15+MPO− (CD15+; non-activated or immature neutrophils; Fig. 3) (CD15+; P = 0.420), or CD15+ expression in malignant tumor cells (PFS CD15+ TC; P = 0.160; Fig. 3).